OUR CLINICAL TRIALS

  • Reset


Translational Study Of Tumor Samples From DS8201- A-U301 and DS8201-A-U302 Trials Leer mas
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Leer mas
A randomized, three-arm, multicenter comparison of 1 year and 2 years of Herceptin® versus no Leer mas
Real world clinical practice study to assess the impact of using comprehensive genomic data on Leer mas
Estudio de práctica clínica del mundo real para evaluar la viabilidad y el impacto del Leer mas
A phase III, multicenter, randomized, open-label study comparing Atezolizumab (anti-PD-L1 antibody) in combination with adjuvant Leer mas
A phase Ib study of Ipatasertib, an AKT inhibitor, in combination with Pertuzumab plus Trastuzumab Leer mas
A phase II Randomized, double-blind study of neoadjuvant Letrozole Plus GDC-0032 versus Letrozole plus placebo Leer mas
A randomized phase II study of Fulvestrant in combination with the dual mTOR inhibitor AZD2014 Leer mas